1,594 Views
Neurodegenerative Disease (e.g. MS, Parkinson's disease)
Clinical Practice (assessment, diagnosis, treatment, knowledge translation/EBP, implementation science, program development)
International
Symposium
Iracema Leroi, BSc, MD, FRCPC, MRCPsych, DABPN
Associate Professor of Geriatric Psychiatry
Global Brain Health Institute, Trinity College Dublin
Dublin
Tammy Hopper, BA, MS, PhD, CCC-SLP
Professor
University of Alberta
Edmonton, Alberta
H. Isabel Hubbard, PhD, CCC-SLP
Assistant Professor
University of Kentucky
Lexington, Kentucky
Carrie Nieman, MD,MPH
Assistant Professor
Johns Hopkins University School of Medicine
Baltimore, Maryland
Fofi Constantinidou, PhD, CCC-S, CBIS
Professor of Language Disorders and Clinical Neuropsychology
University of Cyprus
Nicosia, Nicosia
Hearing and vision impairments are among the most common and disabling comorbidities in dementia and may worsen the trajectory of decline. Improving sensory function may be an accessible and cost-effective means of improving quality of life and other outcomes for people with dementia (PwD). This symposium provides new evidence to guide the clinician in managing these comorbidities, including specific clinical guidelines. It also highlights the unmet needs of minority and low socioeconomic communities with concurrent hearing and cognitive challenges.